A5039083123- Colorectal and Anal Carcinomas
- Hidradenitis Suppurativa and Treatments
- Cutaneous Melanoma Detection and Management
- Microscopic Colitis
- Chemotherapy-related skin toxicity
- Nonmelanoma Skin Cancer Studies
- Infectious Diseases and Mycology
- Cancer and Skin Lesions
- Cutaneous lymphoproliferative disorders research
Hospital Universitario Virgen Macarena
2020-2022
Hospital Universitario De Cabueñes
2022
Hospital Jerez Puerta del Sur
2021
. Skin cancer is the most common worldwide. One of non-melanoma tumors basal cell carcinoma (BCC), which accounts for 75% all skin cancers. There are many benign lesions that can be confused with these types cancers, leading to unnecessary biopsies. In this paper, a new method identify different BCC dermoscopic patterns present in lesion presented. addition, information applied classify into and non-BCC.
In developed countries, health care delivery in dermatology is hampered by the low availability of dermatologists.To analyze feasibility a teledermatology-based action plan to provide initial dermatologic areas with dermatologists.A cross-sectional study describing and cost 12-month based on store-and-forward teledermatology (TD) connecting primary centers TD center. Teleconsultations from patients complaining any cutaneous condition were included. The outcome measure was percentage not...
Antibiotics remain one of the main treatment alternatives in mild-to-moderate hidradenitis suppurativa. The use topical 15% resorcinol reduces antibiotic pressure and generation resistance. However, knowledge on its efficacy safety is limited. This single-center, prospective, follow-up cohort study evaluated every 12-h response at 16 weeks. Those individuals with suppurativa (Hurley I-II) who started monotherapy between April 2019 May 2020 were eligible for follow-up. primary endpoint...
<h3>Objectives</h3> Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain lesion duration. The aim of this study to establish topical formula, develop physicochemical microbiological stability further determine the compounding shelf-life different package conditions following European Pharmacopoeia (Ph. Eur.) specifications. <h3>Methods</h3> Physicochemical studies formulation were conducted 12 months at room...